Cipla buys 60% stake in Sri Lankan co for $14m

Tags: Companies
Pharmaceutical firm Cipla Ltd today said it has acquired 60 per cent stake in a new company in Sri Lanka for $14 million (nearly Rs 85 crore) to market its product in the country.

Cipla (Mauritius) Ltd, a wholly owned subsidiary of the Indian company, has signed a definitive agreement with its existing Sri Lankan distributor for acquisition of 60 per cent stake in a new company, Cipla said in a filing to the BSE.

The new company will market the Cipla's products in Sri Lanka, it added.

"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regulatory approvals.

As part of its global expansion, Cipla has been active in acquisitions.

Last year, it completed the buyout of South African pharma firm Cipla Medpro for Rs 2,707 crore.

Cipla had also acquired Croatia-based firm Celeris, distributor of its products in that country last December.

Shares of Cipla were trading at Rs 411.30 per scrip in the afternoon trade, down 0.56 per cent from the previous close on the BSE.

EDITORIAL OF THE DAY

  • Modi government needs a 5-year perspective plan for securing India’s computer networks

    Going wholly digital has its own consequences. For one, India will become increasingly vulnerable to deadly cyber attacks, which are a reality today.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Freedom Files : THE LAST SHEPHERD

The deep sense of foreboding was still to set in, ...

Urs Schoettli

Dragon Days are here

This is a very crucial year for the People’s Republic ...

Rajgopal Nidamboor

Your attitude can transform your life

Our attitude reflects our feelings, beliefs, or frame of mind, ...